Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus

  • Peleg, Anton (Primary Chief Investigator (PCI))
  • Roney, Janine (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date18/10/22 → 1/09/24

Keywords

  • Clinical trial
  • Bacteraemia
  • Staphylococcus aureus
  • antibiotic therapy

Clinical Trial Phase

  • Phase I
  • Phase II